Patent · US Active

Triazine based radiopharmaceuticals and radioimaging agents

US11712485B2 · kind B2 · utility

0Cited by
30References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 21, 2020
Grant dateAug 1, 2023
Priority date—
Expiry dateDec 21, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F5/003
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Metal complexes including a radionuclide and a compound of Formula I and Formula II are potent inhibitors of PSMA.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.